In The News

SEPTEMBER 2017
The Brain of Ben Barres
Discover; Kenneth Miller

August 18, 2017
Beyond amyloid’: A look at what’s next in Alzheimer’s research
STAT; Damian Garde

December 16, 2016
Japanese Interview with MSA Partners US Pharmaceutical Industry Newsletter

October 18, 2016
19 Bay Area Biotechs to Watch at BIO's Investor Forum This Week
BioSpace.com

September 19, 2016
FierceBiotech names Annexon Biosciences as one of its “Fierce 15” Biotech Companies of 2016
FierceBiotech

June 24, 2016
Annexon seeks answers in complement-mediated neurodegeneration with $44M series B
BioWorld

June 23, 2016
NEA leads $44M round to get Stanford neurodegenerative spinout Annexon into the clinic
FierceBiotech

June 23, 2016
Annexon Gets $44M To See If Protecting Synapses Will Help Fight Alzheimer’s
Forbes

June 23, 2016
Is this the drug answer to Alzheimer’s and Huntington’s disease?
SF Business Times

APRIL 1, 2016
New Clues Show Out-of-Control Synapse Pruning May Underlie Alzheimer’s
Scientific American

APRIL 1, 2016
Alzheimer’s may be caused by haywire immune system eating brain connections
Science

JANUARY 7, 2016
The road less traveled: Start-ups invest in novel approaches against neurodegeneration
Nature Medicine

JULY 24, 2014
Rethinking Alzheimer’s – Looking to its origins for a treatment
Stanford Medicine Magazine

NOVEMBER 15, 2013
The Inconstant Gardener
Science News, Nov 2013, Synaptic Sculpting

AUGUST 14, 2013
A potential cure for Alzheimer’s? Scientists discover new culprit behind brain-wasting disease
Fox News

AUGUST 13, 2013
Stanford spinout takes new angle against Alzheimer’s, MS, other diseases
San Francisco Business Times

AUGUST 13, 2013
Study identifies new culprit that may make aging brains susceptible to neurodegenerative diseases
Stanford Medicine

JANUARY 22, 2013
Microglial Cells may be Tied to Dementia
SF Gate